| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Amylin Shares Jump as Sanofi, Merck Sumbit Bids | | 7 | Benzinga.com |
| 25.05.
| Reports: Sanofi, Merck Bid At Least $25 Per Share For Amylin | | 9 | Barron's |
| 25.05.
| Amylin Said to Draw First-Round Bids From Sanofi, Merck | | 5 | Bloomberg |
| 25.05.
| Government Of Rwanda Launches Merck's ROTATEQ To Prevent Rotavirus | | 82 | AFX News |
| WHITEHOUSE STATION (dpa-AFX) - Merck & Co Inc. (MRK), known as MSD outside
the United States and Canada, introduced in Rwanda of Africa's first national
rotavirus vaccination program with...
Mehr lesen zu:
Government Of Rwanda Launches Merck's ROTATEQ To Prevent Rotavirus | |
| 25.05.
| Government of Rwanda Introduces Merck's ROTATEQ | | - | Benzinga.com |
| 25.05.
| Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus | | 54 | Business Wire |
| Merck (NYSE: MRK), known as MSD outside the United States and Canada,
welcomes today's launch in Rwanda of Africa's first national rotavirus
vaccination program with ROTATEQ®...
Mehr lesen zu:
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus | |
| 25.05.
| FDA Nod for Merck Drug Label Update | | 1 | Zacks |
| 24.05.
| Merck and Mylan Look to Benefit From Plan to Speed up FDA Reviews / Five Star Equities Provides Stock Research on Merck and Mylan | | 50 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 05/24/12 -- Lost revenues as a result of expiring patents have been a growing problem for the big pharmaceutical companies. New products that are being introduced into...
Mehr lesen zu:
Merck and Mylan Look to Benefit From Plan to Speed up FDA Reviews / Five Star Equities Provides Stock Research on Merck and Mylan | |
| 23.05.
| Merck Approaches New Downside Target of $37.13 | | - | SmarTrend |
| 23.05.
| Codexis extends process development collaboration with Merck | | 2 | Pharma Bus Review
|
| 23.05.
| Pharmariese Merck - Co. zahlt unverändert 42 US-Cents Dividende | | 5 | MyDividends.de |
| 22.05.
| Merck Announces Third-Quarter 2012 Dividend | | 80 | Business Wire |
| At their meeting today, the Board of Directors of Merck & Co., Inc.
declared a quarterly dividend of $0.42 per share on the company's common
stock for the third quarter...
Mehr lesen zu:
Merck Announces Third-Quarter 2012 Dividend | |
| 22.05.
| Analysis And Valuation: Johnson & Johnson, Pfizer, And Merck | | 18 | Seeking Alpha |
| 22.05.
| Merck CEO: Generics, economy to make 2012-13 tough | | 7 | Yahoo-USA |
| 22.05.
| Merck: Manufacturing Portfolio Health With Dividend Income | | 3 | Seeking Alpha |
| 21.05.
| 4-Star Stocks Poised to Pop: Merck | | 1 | Motley Fool |
| 21.05.
| Merck: FDA Approves New Labeling for ISENTRESS to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability | | 2 | Benzinga.com |
| 18.05.
| Merck Among 5 Interesting Plays To Consider | | 4 | Seeking Alpha |
| 15.05.
| Next Support Level for Merck is $37.43 | | - | SmarTrend |
| 11.05.
| Merck Approaches New Downside Target of $38.05 | | 3 | SmarTrend |
